Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 9 | 2024 | 356 | 2.560 |
Why?
|
| Apolipoprotein E4 | 3 | 2024 | 24 | 1.050 |
Why?
|
| Lysosomes | 2 | 2024 | 65 | 0.730 |
Why?
|
| Epilepsy | 3 | 2013 | 191 | 0.680 |
Why?
|
| Autophagy | 2 | 2024 | 185 | 0.670 |
Why?
|
| Ubiquitination | 1 | 2019 | 57 | 0.620 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 84 | 0.600 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 132 | 0.590 |
Why?
|
| Nucleotide Motifs | 1 | 2017 | 22 | 0.540 |
Why?
|
| Apolipoprotein E3 | 2 | 2017 | 9 | 0.510 |
Why?
|
| Brain | 2 | 2017 | 1337 | 0.440 |
Why?
|
| Neuroimmunomodulation | 1 | 2013 | 13 | 0.410 |
Why?
|
| Temporal Lobe | 1 | 2013 | 70 | 0.400 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 58 | 0.390 |
Why?
|
| Neurons | 2 | 2012 | 442 | 0.330 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2010 | 17 | 0.320 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2010 | 23 | 0.320 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 12 | 0.320 |
Why?
|
| Endosomes | 1 | 2010 | 34 | 0.320 |
Why?
|
| Peptide Fragments | 1 | 2010 | 214 | 0.300 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 36 | 0.280 |
Why?
|
| Models, Molecular | 2 | 2019 | 356 | 0.270 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 193 | 0.260 |
Why?
|
| Microglia | 2 | 2006 | 139 | 0.260 |
Why?
|
| Depressive Disorder | 1 | 2009 | 335 | 0.250 |
Why?
|
| Interleukin-1 | 2 | 2006 | 102 | 0.250 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 148 | 0.240 |
Why?
|
| Genotype | 2 | 2017 | 563 | 0.210 |
Why?
|
| Aged | 6 | 2019 | 10242 | 0.200 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 135 | 0.190 |
Why?
|
| Mice | 2 | 2024 | 5899 | 0.180 |
Why?
|
| Inflammation | 1 | 2006 | 649 | 0.180 |
Why?
|
| Down Syndrome | 3 | 2010 | 92 | 0.180 |
Why?
|
| Aging | 1 | 2006 | 722 | 0.170 |
Why?
|
| Ubiquitin | 1 | 2019 | 70 | 0.160 |
Why?
|
| Enzyme Activation | 1 | 2019 | 269 | 0.150 |
Why?
|
| Protein Transport | 1 | 2019 | 172 | 0.150 |
Why?
|
| Disease Progression | 2 | 2017 | 870 | 0.150 |
Why?
|
| Humans | 9 | 2019 | 52441 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 19 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 29 | 0.140 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 71 | 0.140 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 74 | 0.140 |
Why?
|
| Female | 5 | 2019 | 28277 | 0.130 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 93 | 0.130 |
Why?
|
| Animals | 2 | 2024 | 13485 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2017 | 285 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 2 | 2010 | 73 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1558 | 0.120 |
Why?
|
| Male | 4 | 2019 | 26874 | 0.120 |
Why?
|
| Protein Binding | 1 | 2017 | 673 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 622 | 0.110 |
Why?
|
| Infant | 2 | 2013 | 3709 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2013 | 4046 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1134 | 0.110 |
Why?
|
| Young Adult | 2 | 2013 | 4346 | 0.100 |
Why?
|
| Neuroglia | 1 | 2012 | 39 | 0.090 |
Why?
|
| Alleles | 1 | 2012 | 279 | 0.090 |
Why?
|
| Adolescent | 2 | 2013 | 6713 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 580 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2012 | 587 | 0.080 |
Why?
|
| Middle Aged | 3 | 2013 | 13133 | 0.080 |
Why?
|
| Child | 2 | 2013 | 7194 | 0.080 |
Why?
|
| Adult | 3 | 2013 | 14205 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 977 | 0.080 |
Why?
|
| Injections, Spinal | 1 | 2008 | 22 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1099 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 390 | 0.060 |
Why?
|
| Nerve Growth Factors | 1 | 2006 | 26 | 0.060 |
Why?
|
| S100 Proteins | 1 | 2006 | 33 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2002 | 6 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2002 | 14 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2002 | 26 | 0.050 |
Why?
|
| Age of Onset | 1 | 2002 | 109 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 184 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 3449 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2002 | 158 | 0.040 |
Why?
|
| Astrocytes | 1 | 2002 | 148 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 201 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 525 | 0.040 |
Why?
|